New Study of Depressive Symptoms in Parkinson's Disease Patients Shows Positive Results for Mirapex: "Results from a small scale, open-label, multicenter, randomized, active-controlled study demonstrated that Mirapex® (pramipexole dihydrochloride) tablets, a dopamine agonist indicated for the treatment of Parkinson's disease (PD), provided similar improvement of depressive symptoms in Parkinson's disease patients as sertraline, an established antidepressant. This prospective study, published in the Journal of Neurology, found pramipexole to have an antidepressant effect in PD patients who had major depression and no history of motor complications and/or dyskinesia and taking stable levodopa treatment.....